Grand Rounds

Clinical Oncology and Hematology Grand Rounds - Phase II Study of Panitumumab Plus Irinotecan as Second-Line Therapy for Advanced Esophageal Adenocarcinoam



Date
April 3, 2013
Time
8:00 AM - 9:00 AM
Speaker(s)
Yang Liu, MD, PhD
Fellow, Division of Hematology/Oncology
Location
UPMC Cancer Pavilion, 2nd floor auditorium, Herberman Conference Center
Category
University of Pittsburgh - School of Medicine - Medicine - Hematology/Oncology
Contact
Carolyn Miller
Conference Coordinator


412-692-2751
millerc5@upmc.edu